News

  • 17 November 2011

    Landauer acquires IZI Medical Products

    Landauer, a provider of personal and environmental radiation monitoring services, has acquired all outstanding equity interests of US-based IZI Medical Products for around $93m.

  • 16 November 2011

    MDxHealth prostate cancer assay shows efficacy

    MDxHealth's Prostate ConfirmMDx test has been found to help urologists to distinguish between true negative biopsies and occult prostate cancers undetected by biopsy and histopathological review.

  • 15 November 2011

    Elixir initiates DESolve bioresorbable coronary system study

    Elixir Medical has begun patient enrolment in an international pivotal clinical study to assess the safety and efficacy of its DESolve novolimus-eluting bioresorbable coronary scaffold system for treating coronary blockages.

Close
Close
Close

Go Top